pharmaceutical investing InMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update
pharmaceutical investing InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance
pharmaceutical investing InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program
pharmaceutical investing InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
pharmaceutical investing InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
pharmaceutical investing InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
pharmaceutical investing InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901
Edgewater Wireless Reports Fiscal 2026 Year-End Results and Highlights Growing Semiconductor Execution and Industry Validation
Silver Hammer and Stroud Resources Announce Updated Mineral Resource Estimate for the Santo Domingo Silver-Gold Project, Mexico
